0

Global Gastroparesis Drugs Market 2017-2021

  • Published: May 2017
  • Pages: 70
  • SKU: IRTNTR13089
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This market research study identifies Cadila Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, and Valeant as the leading players in the global gastroparesis drugs market. A comprehensive analysis of this market is also presented by the disease type (diabetic gastroparesis, idiopathic gastroparesis, and others), by drug class (prokinetic agents, antiemetic agents, and botulinum toxin injection), and by geography (the Americas, APAC, and EMEA).

Gastroparesis drugs market analysis

As per the Technavio’s market research report, the global gastroparesis drugs market is expected to grow at a steady rate and post a CAGR of more than 3% during the forecast period. The rising number of gastric surgeries that fuel the prevalence rate of post-surgical gastroparesis will drive the growth prospects for the global gastroparesis drugs market throughout the projected period. After idiopathic and diabetic gastroparesis, post-surgical gastroparesis is the third most common type of gastroparesis seen in patients.

There is a high chance that the vagus nerves get injured during a gastric surgery that are done to digestive parts such as the esophagus, duodenum, and stomach. With gastric bypass surgeries and bariatric surgeries being commonly performed, this rise in number of gastric surgeries will consequently drive the demand for gastroparesis drugs.

Gastroparesis drugs market growth based on regions

In terms of geography, the Americas were the largest market for gastroparesis drugs during 2016 and this attributed to the high per capita disposable income. Factors such as the growing number of diabetic patients, the growing need for proper treatment options for the disease, and the absence of US FDA-approved treatment for idiopathic gastroparesis in the US, have created a high demand for the development of more drugs in the region, which will in turn, fuel the growth of the gastroparesis market in this region during the predicted period.

Gastroparesis drugs market opportunities for key vendors

The global gastroparesis drugs market is competitive and diversified due to the presence of a large number of regional and international vendors. These vendors are increasingly competing against each other based on factors such as new indications and new route of administrations. Vendors are increasingly focusing on providing effective drugs for new indications as they are expected to develop drugs for various types of diseases such as idiopathic gastroparesis. Moreover, several vendors are also taking efforts to enhance their geographical reach and expand their product portfolios by adopting M&A strategies.

Key vendors in the gastroparesis drugs market

  • Cadila Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Valeant

Gastroparesis drugs market segmentation by disease type

  • Diabetic gastroparesis
  • Idiopathic gastroparesis

The idiopathic gastroparesis segment dominated the global gastroparesis drugs market during 2016 and the segment is expected to continue its dominance during the next four years as well. The market is witnessing the development of new and effective therapies for the symptomatic control of idiopathic gastroparesis, which will be one of the major factors responsible for the market segment’s growth. Additionally, with the unavailability of FDA-approved drugs for the treatment of idiopathic gastroparesis in countries such as the US, the vendors will increasingly focus on the development of new drugs, which will again propel the growth of the market in this segment.

Gastroparesis drugs market segmentation by drug class

  • Prokinetic agents
  • Antiemetic agents
  • Botulinum toxin injection

During 2016, the prokinetic agents segment accounted for the major shares of the gastroparesis drugs market and according to this market research and analysis, the segment will continue its market dominance during the next few years as well. Prokinetic agents are used to relieve a large number of gastrointestinal (GI) symptoms such as bloating, constipation, abdominal discomfort, vomiting, nausea, and heartburn. Metoclopramide, domperidone, and erythromycin are some of the common prokinetic agents used for the treatment of gastroparesis.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2021?
  • What are the key factors driving the global gastroparesis drugs market?
  • What are the key market trends impacting the growth of the global gastroparesis drugs market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global gastroparesis drugs market?
  • What are the market opportunities and threats faced by the vendors in the global gastroparesis drugs market?
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
  • What are the key outcomes of the five forces analysis of the global gastroparesis drugs market?

Technavio also offers customization on reports based on specific client requirement.

 

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights

PART 05: Disease overview

PART 06: Market landscape

  • Market overview
  • Five forces analysis

PART 07: Pipeline landscape

PART 08: Market segmentation by disease type

  • Diabetic gastroparesis
  • Idiopathic gastroparesis
  • Others

PART 09: Market segmentation by drug class

  • Prokinetic agents
  • Antiemetic agents
  • Botulinum toxin injection

PART 10: Geographical segmentation

  • Gastroparesis drugs market in Americas
  • Gastroparesis drugs market in EMEA
  • Gastroparesis drugs market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges

  • Market drivers
  • Market challenges

PART 13: Market trends

  • Fast track approvals and acquisitions to change the phase of the market
  • Introduction of novel ways for the treatment of gastroparesis symptoms

PART 14: Vendor landscape

  • Competitive scenario
  • Cadila Pharmaceuticals
  • GlaxoSmithKline
  • Johnson & Johnson
  • Valeant
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>